Inhibition of platelet aggegation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ono 41483, in primates
- 30 September 1982
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes and Medicine
- Vol. 9 (3) , 307-320
- https://doi.org/10.1016/s0262-1746(82)80018-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- THROMBOXANE SYNTHETASE INHIBITIONThe Lancet, 1981
- Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in manProstaglandins and Medicine, 1981
- INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATIONThe Lancet, 1981
- ADMINISTRATION TO MAN OF UK-37,248-01, A SELECTIVE INHIBITOR OF THROMBOXANE SYNTHETASEThe Lancet, 1981
- Platelet and other effects of carboprostacyclin - A stable prostacyclin analogueProstaglandins and Medicine, 1980
- Comparison in anesthetized dogs of the anti-aggregatory and hemodynamic effects of prostacyclin and a chemically stable prostacyclin analog, 6a-carba-PGI2 (carbacyclin)Prostaglandins, 1980
- Carbacyclin — A potent stable prost acyclin analogue for the inhibition of platelet aggregationProstaglandins, 1980
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979